Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
C09CA04	APROVEL	B	Irbesartan - 150mg	150mg	Tablet, film coated	651,764 L.L
C09CA04	ANDARAN	G	Irbesartan - 150mg	150mg	Tablet, film coated	940,435 L.L
C09CA04	APROVEL	B	Irbesartan - 300mg	300mg	Tablet, film coated	651,764 L.L
C09CA04	APROVEL	B	Irbesartan - 300mg	300mg	Tablet, film coated	651,764 L.L
C09CA04	ANDARAN	G	Irbesartan - 300mg	300mg	Tablet, film coated	940,435 L.L
C09CA06	ATACAND	B	Candesartan cilexetil - 8mg	8mg	Tablet	526,786 L.L
C09CA06	ANDESART 8	G	Candesartan cilexetil - 8mg	8mg	Tablet	498,566 L.L
C09CA06	ARKANDA 8	G	Candesartan cilexetil - 8mg	8mg	Tablet	639,925 L.L
C09CA06	ATACAND	B	Candesartan cilexetil - 16mg	16mg	Tablet	705,517 L.L
C09CA06	ANDESART 16	G	Candesartan cilexetil - 16mg	16mg	Tablet	665,202 L.L
C09CA06	ARKANDA 16	G	Candesartan cilexetil - 16mg	16mg	Tablet	700,078 L.L
C09CA07	ARBIVASTEL	G	Telmisartan - 80mg	80mg	Tablet	667,890 L.L
C09DA03	ARBITEN PLUS	G	Valsartan - 160mg, Hydrochlorothiazide - 12.5mg		Tablet	544,256 L.L
C09DA03	ARBITEN PLUS	G	Valsartan - 160mg, Hydrochlorothiazide - 25mg		Tablet	579,196 L.L
C09DA04	ANDARAN PLUS	G	Irbesartan - 150mg, Hydrochlorothiazide - 12.5mg		Tablet, film coated	598,051 L.L
C09DA04	ANDARAN PLUS	G	Irbesartan - 300mg, Hydrochlorothiazide - 12.5mg		Tablet, film coated	598,051 L.L
C09DA04	ANDARAN PLUS	G	Irbesartan - 300mg, Hydrochlorothiazide - 25mg		Tablet, film coated	940,435 L.L
C09DA06	ATACAND PLUS	B	Candesartan cilexetil - 16mg, Hydrochlorothiazide - 12.5mg		Tablet	705,517 L.L
C09DA06	ARKANDA PLUS 16/12.5	G	Candesartan cilexetil - 16mg, Hydrochlorothiazide - 12.5mg	32mg	Tablet	854,940 L.L
C09DB01	AMLODIPINE/VALSARTAN ARROW	G	Amlodipine (besylate) - 5mg, Valsartan - 160mg		Tablet, coated	923,220 L.L
C09DB01	ARBITEN AM 5/160	G	Amlodipine - 5mg, Valsartan - 160mg		Caplet, film coated	857,372 L.L
C09DB01	AMLODIPINE/VALSARTAN ARROW	G	Amlodipine (besylate) - 10mg, Valsartan - 160mg		Tablet, coated	923,220 L.L
C09DB01	ANGIOSAR	G	Amlodipine besylate - 10mg, Valsartan - 160mg		Tablet, film coated	857,372 L.L
C09DB01	ARBITEN AM 10/160	G	Amlodipine - 10mg, Valsartan - 160mg		Caplet, film coated	857,372 L.L
C09DB01	AMLODIPINE/VALSARTAN ARROW	G	Amlodipine (besylate) - 5mg, Valsartan - 80mg		Tablet, coated	807,649 L.L
C09DX01	ARBITEN AM PLUS	G	Valsartan - 160mg, Amlodipine - 5mg, Hydrochlorothiazide - 12.5mg		Tablet	857,372 L.L
C09DX01	ANGIOSAR PLUS	G	Valsartan - 320mg, Amlodipine - 10mg, Hydrochlorothiazide - 25mg		Tablet, film coated	1,689,210 L.L
C10AA02	ATERKEY	G	Lovastatin - 20mg	20mg	Tablet	1,053,573 L.L
C10AA03	APO-PRAVASTATIN	G	Pravastatin Sodium - 40mg	40mg	Tablet	958,160 L.L
C10AA03	APO-PRAVASTATIN	G	Pravastatin Sodium - 20mg	20mg	Tablet	775,397 L.L

...